Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR53485
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
All files associated with the entry
Citation: Weiss, Charlotte; Overall, Sarah; Catone, Nicola; Barnes, Alexander; Aichem, Annette; Mathies, Guinevere. "Intermolecular beta-sheet Formation Guides the Interaction between Ubiquitin-like Modifier FAT10 and Adapter Protein NUB1L" J. Am. Chem. Soc. ., .-. (2026).
PubMed: 42159595
Assembly members:
entity_1, polymer, 83 residues, 9400 Da.
entity_2, polymer, 614 residues, 70400 Da.
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pETM30
Entity Sequences (FASTA):
entity_1: GASTLTVHVRSEEWDLMTFD
ANPYDSVKKIKEHVRSKTKV
PVQDQVLLLGSKILKPRRSL
SSYGIDKEKTIHLTLKVVKP
SDE
entity_2: AQKKYLQAKLTQFLREDRIQ
LWKPPYTDENKKVGLALKDL
AKQYSDRLECCENEVEKVIE
EIRCKAIERGTGNDNYRTTG
IATIEVFLPPRLKKDRKNLL
ETRLHITGRELRSKIAETFG
LQENYIKIVINKKQLQLGKT
LEEQGVAHNVKAMVLELKQS
EEDARKNFQLEEEEQNEAKL
KEKQIQRTKRGLEILAKRAA
ETVVDPEMTPYLDIANQTGR
SIRIPPSERKALMLAMGYHE
KGRAFLKRKEYGIALPCLLD
ADKYFCECCRELLDTVDNYA
VLQLDIVWCYFRLEQLECLD
DAEKKLNLAQKCFKNCYGEN
HQRLVHIKGNCGKEKVLFLR
LYLLQGIRNYHSGNDVEAYE
YLNKARQLFKELYIDPSKVD
NLLQLGFTAQEARLGLRACD
GNVDHAATHITNRREELAQI
RKEEKEKKRRRLENIRFLKG
MGYSTHAAQQVLHAASGNLD
EALKILLSNPQMWWLNDSNP
ETDNRQESPSQENIDRLVYM
GFDALVAEAALRVFRGNVQL
AAQTLAHNGGSLPPELPLSP
EDSLSPPATSPSDSAGTSSA
STDEDMETEAVNEILEDIPE
HEEDYLDSTLEDEEIIIAEY
LSYVENRKSATKKN
| Data type | Count |
| 13C chemical shifts | 79 |
| 15N chemical shifts | 19 |
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | entity_1 | 1 |
| 2 | entity_2 | 2 |
Entity 1, entity_1 83 residues - 9400 Da.
N-terminal glycine residue results from TEV protease cleavage site.
| 1 | GLY | ALA | SER | THR | LEU | THR | VAL | HIS | VAL | ARG | ||||
| 2 | SER | GLU | GLU | TRP | ASP | LEU | MET | THR | PHE | ASP | ||||
| 3 | ALA | ASN | PRO | TYR | ASP | SER | VAL | LYS | LYS | ILE | ||||
| 4 | LYS | GLU | HIS | VAL | ARG | SER | LYS | THR | LYS | VAL | ||||
| 5 | PRO | VAL | GLN | ASP | GLN | VAL | LEU | LEU | LEU | GLY | ||||
| 6 | SER | LYS | ILE | LEU | LYS | PRO | ARG | ARG | SER | LEU | ||||
| 7 | SER | SER | TYR | GLY | ILE | ASP | LYS | GLU | LYS | THR | ||||
| 8 | ILE | HIS | LEU | THR | LEU | LYS | VAL | VAL | LYS | PRO | ||||
| 9 | SER | ASP | GLU |
Entity 2, entity_2 614 residues - 70400 Da.
| 1 | ALA | GLN | LYS | LYS | TYR | LEU | GLN | ALA | LYS | LEU | ||||
| 2 | THR | GLN | PHE | LEU | ARG | GLU | ASP | ARG | ILE | GLN | ||||
| 3 | LEU | TRP | LYS | PRO | PRO | TYR | THR | ASP | GLU | ASN | ||||
| 4 | LYS | LYS | VAL | GLY | LEU | ALA | LEU | LYS | ASP | LEU | ||||
| 5 | ALA | LYS | GLN | TYR | SER | ASP | ARG | LEU | GLU | CYS | ||||
| 6 | CYS | GLU | ASN | GLU | VAL | GLU | LYS | VAL | ILE | GLU | ||||
| 7 | GLU | ILE | ARG | CYS | LYS | ALA | ILE | GLU | ARG | GLY | ||||
| 8 | THR | GLY | ASN | ASP | ASN | TYR | ARG | THR | THR | GLY | ||||
| 9 | ILE | ALA | THR | ILE | GLU | VAL | PHE | LEU | PRO | PRO | ||||
| 10 | ARG | LEU | LYS | LYS | ASP | ARG | LYS | ASN | LEU | LEU | ||||
| 11 | GLU | THR | ARG | LEU | HIS | ILE | THR | GLY | ARG | GLU | ||||
| 12 | LEU | ARG | SER | LYS | ILE | ALA | GLU | THR | PHE | GLY | ||||
| 13 | LEU | GLN | GLU | ASN | TYR | ILE | LYS | ILE | VAL | ILE | ||||
| 14 | ASN | LYS | LYS | GLN | LEU | GLN | LEU | GLY | LYS | THR | ||||
| 15 | LEU | GLU | GLU | GLN | GLY | VAL | ALA | HIS | ASN | VAL | ||||
| 16 | LYS | ALA | MET | VAL | LEU | GLU | LEU | LYS | GLN | SER | ||||
| 17 | GLU | GLU | ASP | ALA | ARG | LYS | ASN | PHE | GLN | LEU | ||||
| 18 | GLU | GLU | GLU | GLU | GLN | ASN | GLU | ALA | LYS | LEU | ||||
| 19 | LYS | GLU | LYS | GLN | ILE | GLN | ARG | THR | LYS | ARG | ||||
| 20 | GLY | LEU | GLU | ILE | LEU | ALA | LYS | ARG | ALA | ALA | ||||
| 21 | GLU | THR | VAL | VAL | ASP | PRO | GLU | MET | THR | PRO | ||||
| 22 | TYR | LEU | ASP | ILE | ALA | ASN | GLN | THR | GLY | ARG | ||||
| 23 | SER | ILE | ARG | ILE | PRO | PRO | SER | GLU | ARG | LYS | ||||
| 24 | ALA | LEU | MET | LEU | ALA | MET | GLY | TYR | HIS | GLU | ||||
| 25 | LYS | GLY | ARG | ALA | PHE | LEU | LYS | ARG | LYS | GLU | ||||
| 26 | TYR | GLY | ILE | ALA | LEU | PRO | CYS | LEU | LEU | ASP | ||||
| 27 | ALA | ASP | LYS | TYR | PHE | CYS | GLU | CYS | CYS | ARG | ||||
| 28 | GLU | LEU | LEU | ASP | THR | VAL | ASP | ASN | TYR | ALA | ||||
| 29 | VAL | LEU | GLN | LEU | ASP | ILE | VAL | TRP | CYS | TYR | ||||
| 30 | PHE | ARG | LEU | GLU | GLN | LEU | GLU | CYS | LEU | ASP | ||||
| 31 | ASP | ALA | GLU | LYS | LYS | LEU | ASN | LEU | ALA | GLN | ||||
| 32 | LYS | CYS | PHE | LYS | ASN | CYS | TYR | GLY | GLU | ASN | ||||
| 33 | HIS | GLN | ARG | LEU | VAL | HIS | ILE | LYS | GLY | ASN | ||||
| 34 | CYS | GLY | LYS | GLU | LYS | VAL | LEU | PHE | LEU | ARG | ||||
| 35 | LEU | TYR | LEU | LEU | GLN | GLY | ILE | ARG | ASN | TYR | ||||
| 36 | HIS | SER | GLY | ASN | ASP | VAL | GLU | ALA | TYR | GLU | ||||
| 37 | TYR | LEU | ASN | LYS | ALA | ARG | GLN | LEU | PHE | LYS | ||||
| 38 | GLU | LEU | TYR | ILE | ASP | PRO | SER | LYS | VAL | ASP | ||||
| 39 | ASN | LEU | LEU | GLN | LEU | GLY | PHE | THR | ALA | GLN | ||||
| 40 | GLU | ALA | ARG | LEU | GLY | LEU | ARG | ALA | CYS | ASP | ||||
| 41 | GLY | ASN | VAL | ASP | HIS | ALA | ALA | THR | HIS | ILE | ||||
| 42 | THR | ASN | ARG | ARG | GLU | GLU | LEU | ALA | GLN | ILE | ||||
| 43 | ARG | LYS | GLU | GLU | LYS | GLU | LYS | LYS | ARG | ARG | ||||
| 44 | ARG | LEU | GLU | ASN | ILE | ARG | PHE | LEU | LYS | GLY | ||||
| 45 | MET | GLY | TYR | SER | THR | HIS | ALA | ALA | GLN | GLN | ||||
| 46 | VAL | LEU | HIS | ALA | ALA | SER | GLY | ASN | LEU | ASP | ||||
| 47 | GLU | ALA | LEU | LYS | ILE | LEU | LEU | SER | ASN | PRO | ||||
| 48 | GLN | MET | TRP | TRP | LEU | ASN | ASP | SER | ASN | PRO | ||||
| 49 | GLU | THR | ASP | ASN | ARG | GLN | GLU | SER | PRO | SER | ||||
| 50 | GLN | GLU | ASN | ILE | ASP | ARG | LEU | VAL | TYR | MET | ||||
| 51 | GLY | PHE | ASP | ALA | LEU | VAL | ALA | GLU | ALA | ALA | ||||
| 52 | LEU | ARG | VAL | PHE | ARG | GLY | ASN | VAL | GLN | LEU | ||||
| 53 | ALA | ALA | GLN | THR | LEU | ALA | HIS | ASN | GLY | GLY | ||||
| 54 | SER | LEU | PRO | PRO | GLU | LEU | PRO | LEU | SER | PRO | ||||
| 55 | GLU | ASP | SER | LEU | SER | PRO | PRO | ALA | THR | SER | ||||
| 56 | PRO | SER | ASP | SER | ALA | GLY | THR | SER | SER | ALA | ||||
| 57 | SER | THR | ASP | GLU | ASP | MET | GLU | THR | GLU | ALA | ||||
| 58 | VAL | ASN | GLU | ILE | LEU | GLU | ASP | ILE | PRO | GLU | ||||
| 59 | HIS | GLU | GLU | ASP | TYR | LEU | ASP | SER | THR | LEU | ||||
| 60 | GLU | ASP | GLU | GLU | ILE | ILE | ILE | ALA | GLU | TYR | ||||
| 61 | LEU | SER | TYR | VAL | GLU | ASN | ARG | LYS | SER | ALA | ||||
| 62 | THR | LYS | LYS | ASN |
sample_1: N-FAT10-C0, [U-100% 13C; U-100% 15N], 1.5 mg/mL; NUB1L 10 mg/mL; HEPES 20 mM; sodium chloride 150 mM; TCEP 0.5 mM
sample_conditions_1: pH: 7.5; pressure: 1 atm; temperature: 277 K
| Name | Sample | Sample state | Sample conditions |
|---|---|---|---|
| 2D 13C-13C DARR | sample_1 | isotropic | sample_conditions_1 |
| 2D 15N-13C ZF TEDOR | sample_1 | isotropic | sample_conditions_1 |
| 3D 15N-13C-13C ZF TEDOR DARR | sample_1 | isotropic | sample_conditions_1 |
| 3D NCOCX | sample_1 | isotropic | sample_conditions_1 |
TOPSPIN - collection
NMRPipe - processing
CcpNMR - chemical shift assignment